Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron vs Solifenacin in OAB (BEYOND)
NCT01638000Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Jun 2012; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01638000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638000.